| Obtaining reimbursement for pharmaceuticals is often described as the fourth hurdle and is an essential part of any successful commercialisation strategy. Fios Pharma has in-depth experience with health technology assessment (HTA) submissions and can provide client companies with clear, practical advice on the optimum market access strategy for your drug asset or technology. |  |
